Revisão Acesso aberto

BI-RADS 3: Current and Future Use of Probably Benign

2018; Springer Science+Business Media; Volume: 6; Issue: 2 Linguagem: Inglês

10.1007/s40134-018-0266-8

ISSN

2167-4825

Autores

Karen A. Lee, Nishi Talati, Rebecca Oudsema, Sharon Steinberger, Laurie R. Margolies,

Tópico(s)

AI in cancer detection

Resumo

Probably benign (BI-RADS 3) causes confusion for interpreting physicians and referring physicians and can induce significant patient anxiety. The best uses and evidence for using this assessment category in mammography, breast ultrasound, and breast MRI will be reviewed; the reader will have a better understanding of how and when to use BI-RADS 3.Interobserver variability in the use of BI-RADS 3 has been documented. The 5th edition of the BI-RADS atlas details the appropriate use of BI-RADS 3 for diagnostic mammography, ultrasound, and MRI, and discourages its use in screening mammography. Data mining, elastography, and diffusion weighted MRI have been evaluated to maximize the accuracy of BI-RADS 3.BI-RADS 3 is an evolving assessment category. When used properly, it reduces the number of benign biopsies while allowing the breast imager to maintain a high sensitivity for the detection of early stage breast cancer.

Referência(s)